CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW
Cingulate Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$4.36+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $57.49M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
2M
Shares held, 13F filers
Institutional holders
33
10 new, 4 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
5 buys · 0 sales
Net bought $656.96K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Falcon Creek Capital Advisor LLC | 3,856,766 | 28.50% | 13D (active) amendment | Mar 24, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CING | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 570,873 | – | $3.12M | +261,906 | 0.00% |
| Chicago Partners Investment Group LLC | 188,429 | – | $912.00K | +169,679 | 0.02% |
| Raymond James Financial Inc | 166,898 | – | $912.93K | New | 0.00% |
| Kestra Advisory Services, LLC | 151,500 | – | $828.71K | +11,500 | 0.00% |
| Geode Capital Management, LLC | 144,636 | – | $791.37K | +43,263 | 0.00% |
| Renaissance Technologies LLC | 127,500 | – | $697.43K | +95,612 | 0.00% |
| Vanguard Fiduciary Trust Co | 79,160 | – | $433.01K | +29,086 | 0.00% |
| BlackRock, Inc. | 53,130 | – | $290.62K | +29,861 | 0.00% |
| BCV Asset Management Inc. | 51,200 | – | $272.94K | – | 0.01% |
| State Street Corp | 47,888 | – | $261.95K | +20,300 | 0.00% |
| Northern Trust Corp | 35,121 | – | $192.11K | +12,849 | 0.00% |
| Quantum Private Wealth, LLC | 30,000 | – | $164.10K | +20,000 | 0.04% |
| Prospera Financial Services Inc | 29,900 | – | $163.55K | +8,100 | 0.00% |
| Jane Street Group, LLC | 28,878 | – | $157.96K | −61,989 | 0.00% |
| UBS Group AG | 25,947 | – | $141.93K | +14,914 | 0.00% |
| Mariner, LLC | 21,281 | – | $116.41K | +8,351 | 0.00% |
| XTX Topco Ltd | 20,818 | – | $113.87K | −32,685 | 0.00% |
| Jump Financial, LLC | 14,638 | – | $80.07K | New | 0.00% |
| Virtu Financial LLC | 12,056 | – | $66 | −15,472 | 0.00% |
| PKS Advisory Services, LLC | 11,500 | – | $62.91K | New | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 33 | 2M | 10 / 15 | 4 / 4 | 1M | 0M |
| Q1 2026 | 27 | 1M | 14 / 7 | 3 / 4 | 1M | 0M |
| Q4 2025 | 18 | 1M | 7 / 6 | 4 / 1 | 0M | 0M |
| Q3 2025 | 12 | 0M | 3 / 5 | 4 / 6 | 0M | 0M |
| Q2 2025 | 15 | 0M | 6 / 5 | 2 / 0 | 0M | 0M |
| Q1 2025 | 9 | 0M | 2 / 5 | 1 / 1 | 0M | 0M |
| Q4 2024 | 9 | 0M | 3 / 3 | 3 / 4 | 0M | 0M |
| Q3 2024 | 10 | 0M | 10 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CING | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 394,555 | – | $2.16M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 160,396 | – | $877.37K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 42,839 | – | $178.21K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 27,990 | – | $153.11K | 0.01% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 22,533 | – | $93.74K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 10,991 | – | $45.72K | 0.00% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 10,246 | – | $56.05K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 8,474 | – | $35.25K | 0.00% | May 31, 2026 |
| Vanguard Balanced Index Fund | 5,676 | – | $31.05K | 0.00% | Jun 30, 2026 |
| 1290 VT Micro Cap Portfolio | 1,871 | – | $10.23K | 0.00% | Jun 30, 2026 |
| Total Stock Market Index Trust | 246 | – | $1.35K | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -4,100 | – | -$22.43K | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Shane J. Schaffer | Chief Executive Officer, Director | 17,210 | Jul 20, 2026 |
| Matthew Brams | EVP and Chief Medical Officer | 9,182 | Jul 20, 2026 |
| Jennifer L. Callahan | EVP and CFO | 20,388 | Jul 20, 2026 |
| Raul R. Silva | EVP and CSO | 4,645 | Jul 20, 2026 |
| Bryan Wade Downey | EVP & Chief Commercial Officer | – | Jul 20, 2026 |
| Nilay Dahyabhai Patel | EVP, CLO and CCO | 5,475 | Mar 11, 2026 |
| Laurie Myers | EVP and COO | 0 | Jul 9, 2025 |
| Peter J. Werth | Director | 117,541 | Jul 20, 2026 |
| Bryan Jay Lawrence | Director | – | Jul 20, 2026 |
| Thomas Jeffrey Hargroves | Director | 105,768 | Jul 20, 2026 |
| John A. Roberts | Director | – | Jun 23, 2025 |
| Jeffrey S. Ervin | Director | – | Jun 23, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Shane J. Schaffer Chief Executive Officer, Director | Mar 9, 2026 | Award | +6,862 | – | – | 7,035 |
| Shane J. Schaffer Chief Executive Officer, Director | Mar 9, 2026 | Tax withholding | −2,959 | – | – | 4,076 |
| Jennifer L. Callahan EVP and CFO | Mar 9, 2026 | Award | +15,329 | – | – | 20,388 |
| Jennifer L. Callahan EVP and CFO | Mar 9, 2026 | Tax withholding | −6,427 | – | – | 13,961 |
| Nilay Dahyabhai Patel EVP, CLO and CCO | Mar 9, 2026 | Award | +5,475 | – | – | 5,475 |
| Nilay Dahyabhai Patel EVP, CLO and CCO | Mar 9, 2026 | Tax withholding | −2,086 | – | – | 3,389 |
| Matthew Brams EVP and Chief Medical Officer | Mar 9, 2026 | Award | +4,526 | – | – | 9,182 |
| Matthew Brams EVP and Chief Medical Officer | Mar 9, 2026 | Tax withholding | −1,025 | – | – | 8,157 |
| Raul R. Silva EVP and CSO | Mar 9, 2026 | Tax withholding | −1,828 | – | – | 4,645 |
| Raul R. Silva EVP and CSO | Mar 9, 2026 | Award | +4,526 | – | – | 6,473 |
| Thomas Jeffrey Hargroves Director | Feb 13, 2026 | Buy | +97,276 | $5.04 | $490.27K | 97,468 |
| Matthew Brams EVP and Chief Medical Officer | Feb 6, 2026 | Buy | +1,946 | $5.04 | $9.81K | 4,656 |
| Shane J. Schaffer Chief Executive Officer, Director | Feb 6, 2026 | Buy | +6,809 | $5.04 | $34.32K | 10,175 |
| Jennifer L. Callahan SVP and CFO | Feb 6, 2026 | Buy | +4,864 | $5.04 | $24.51K | 5,059 |
| Peter J. Werth Director | Feb 6, 2026 | Buy | +19,455 | $5.04 | $98.05K | 117,449 |
| Laurie Myers EVP and COO | Aug 15, 2024 | Sale | −202 | $4.17 | $842 | 0 |
| Peter J. Werth Director, 10% owner | Apr 11, 2024 | Option exercise | +694,096 | – | – | 1,175,925 |
| Peter J. Werth Director, 10% owner | Apr 11, 2024 | Option exercise | +341,912 | – | – | 481,829 |
| Jennifer L. Callahan Corporate Controller | Sep 15, 2023 | Buy | +5,000 | $0.67 | $3.35K | 45,508 |
| Peter J. Werth Director | Aug 11, 2023 | Buy | +1,823,155 | $0.55 | $1.00M | 2,798,320 |
| Jennifer L. Callahan Corporate Controller | May 15, 2023 | Buy | +2,000 | $1.01 | $2.02K | 40,508 |
| Jennifer L. Callahan Corporate Controller | May 12, 2023 | Buy | +4,000 | $1.08 | $4.32K | 38,508 |
| Shane J. Schaffer Chief Executive Officer, Director | Dec 16, 2022 | Buy | +10,000 | $1.02 | $10.20K | 41,500 |
| Jennifer L. Callahan Corporate Controller | Dec 14, 2022 | Buy | +7,548 | $0.99 | $7.47K | 34,508 |
| Shane J. Schaffer Chief Executive Officer, Director | Dec 14, 2022 | Buy | +13,267 | $1.01 | $13.40K | 31,500 |
| Shane J. Schaffer Chief Executive Officer, Director | Dec 13, 2022 | Buy | +1,733 | $1.01 | $1.75K | 18,233 |
| Peter J. Werth Director | Dec 13, 2022 | Buy | +28,934 | $0.98 | $28.36K | 975,165 |
| Jennifer L. Callahan Corporate Controller | Nov 29, 2022 | Buy | +1,530 | $0.98 | $1.50K | 26,960 |
| Jennifer L. Callahan Corporate Controller | Nov 28, 2022 | Buy | +3,487 | $0.98 | $3.42K | 25,430 |
| Laurie Myers EVP and COO | Nov 23, 2022 | Buy | +1,111 | $0.90 | $1,000 | 48,263 |
| Craig S. Gilgallon EVP, GC and Secretary | Nov 23, 2022 | Buy | +3,575 | $0.84 | $3.00K | 9,550 |
| Gregg Wm Givens Director | Nov 22, 2022 | Buy | +85,000 | $0.88 | $74.80K | 154,318 |
| Jennifer L. Callahan Corporate Controller | Sep 8, 2022 | Buy | +3,500 | $1.50 | $5.25K | 21,943 |
| Peter J. Werth Director | Sep 6, 2022 | Buy | +74,500 | $1.52 | $113.24K | 946,231 |
| Laurie Myers EVP and COO | Sep 1, 2022 | Buy | +636 | $1.57 | $999 | 47,352 |
| Laurie Myers EVP and COO | Jun 1, 2022 | Buy | +200 | $1.18 | $236 | 46,716 |
| Laurie Myers EVP and COO | May 24, 2022 | Gift | −200 | – | – | 47,152 |
| Laurie Myers EVP and COO | May 17, 2022 | Buy | +200 | $1.21 | $242 | 46,516 |
| Curtis Medeiros Director | May 6, 2022 | Sale | −17,532 | $1.27 | $22.27K | 0 |
| Peter J. Werth Director | Mar 17, 2022 | Buy | +27,000 | $1.79 | $48.33K | 871,731 |
| Laurie Myers EVP and COO | Mar 16, 2022 | Buy | +353 | $1.40 | $494 | 46,316 |
| Jennifer L. Callahan Corporate Controller | Mar 16, 2022 | Buy | +1,900 | $1.39 | $2.64K | 18,443 |
| Jennifer L. Callahan SVP and CFO | Mar 15, 2022 | Buy | +55 | $27.10 | $1.49K | 2,333 |
| Gregg Wm Givens Director | Mar 15, 2022 | Buy | +4,000 | $1.37 | $5.48K | 10,000 |
| Gregg Wm Givens Director | Mar 15, 2022 | Buy | +4,000 | $1.37 | $5.48K | 10,000 |
| Gregg Wm Givens Director | Mar 15, 2022 | Buy | +27,000 | $1.38 | $37.26K | 69,318 |
| Gregg Wm Givens Director | Mar 15, 2022 | Buy | +4,000 | $1.38 | $5.52K | 10,000 |
| Gregg Wm Givens Director | Mar 14, 2022 | Buy | +9,000 | $1.32 | $11.88K | 42,318 |
| Gregg Wm Givens Director | Mar 14, 2022 | Buy | +6,000 | $1.30 | $7.80K | 6,000 |
| Gregg Wm Givens Director | Mar 14, 2022 | Buy | +6,000 | $1.30 | $7.80K | 6,000 |
| Gregg Wm Givens Director | Mar 14, 2022 | Buy | +6,000 | $1.29 | $7.74K | 6,000 |
| Horn Louis G. Van EVP and CFO | Mar 14, 2022 | Buy | +15,000 | $1.34 | $20.10K | 15,000 |
| Curtis Medeiros Director | Mar 14, 2022 | Buy | +17,532 | $1.41 | $24.72K | 17,532 |
| Jennifer L. Callahan Corporate Controller | Mar 14, 2022 | Buy | +12,000 | $1.46 | $17.52K | 16,543 |
| Craig S. Gilgallon EVP & General Counsel | Mar 14, 2022 | Buy | +5,975 | $1.38 | $8.25K | 5,975 |
| Peter J. Werth Director | Dec 10, 2021 | Buy | +8,300 | – | – | 844,731 |
| Thomas Jeffrey Hargroves Director | Dec 10, 2021 | Buy | +8,300 | – | – | 8,300 |
| Gregg Wm Givens Director | Dec 10, 2021 | Buy | +16,500 | – | – | 33,318 |
| Shane J. Schaffer Chief Executive Officer, Director | Dec 10, 2021 | Buy | +16,500 | – | – | 16,500 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.